IDEX announces $0.71 quarterly dividend payment for January 2026

NORTHBROOK, Ill. - IDEX Corporation (NYSE:IEX) announced Thursday that its Board of Directors has approved a regular quarterly cash dividend of $0.71 per common share. The dividend will be paid on January 30, 2026, to shareholders of record as of January 16, 2026. With a current yield of 1.67%, IDEX is trading slightly below its Fair Value according to InvestingPro analysis.

This payment marks IDEX’s 125th consecutive quarterly cash dividend, according to the company’s press release statement. InvestingPro data reveals IDEX has maintained dividend payments for 31 consecutive years and has raised its dividend for 16 consecutive years, demonstrating strong commitment to shareholder returns.

IDEX Corporation operates through three primary business segments: Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety / Diversified Products. The company, founded in 1988, includes more than 50 businesses worldwide with manufacturing operations in over 20 countries.

The engineered products company designs and manufactures components for various industries, including satellite communications, water systems, medical diagnostics, and emergency rescue tools.

In other recent news, IDEX Corporation reported financial results for the third quarter of 2025 that exceeded expectations. The company announced earnings per share of $2.03, surpassing the anticipated $1.93, which represents a 5.18% surprise. Revenue for the quarter reached $878.7 million, also beating the forecast of $861.4 million. These results highlight the company’s robust performance in the period. Additionally, there have been no recent updates on mergers or acquisitions involving IDEX Corporation. In terms of analyst activity, there have been no reported upgrades or downgrades from major firms. Investors are likely to focus on these recent developments as they assess the company’s financial health and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.